Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02588664 · ClinicalTrials.gov registry record · NA
Comprehensive Post-Acute Stroke Services
A NA study of Stroke and Transient Ischemic Attack, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 6,024
- Enrollment target
- 20
- Study locations
NCT02588664: Completed NA study of Stroke and Transient Ischemic Attack, sponsored by Wake Forest University Health Sciences.
NCT02588664 is a NA study of Stroke and Transient Ischemic Attack that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 6,024 participants, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower). The trial reports 20 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02588664, a NA study of Stroke and Transient Ischemic Attack, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,024 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this pragmatic study is to investigate whether implementation of a comprehensive post-acute stroke service model that integrates Early Supported Discharge (ESD) and Transitional Care Management (TCM) for stroke survivors discharged home improves functional outcomes post-stroke, reduces caregiver stress, and reduces readmission rates.
Primary Outcome
16-item survey to assess the difficulty level of performing basic physical activities; scores range from 0-100; higher scores correspond to more favorable outcomes
Conditions Studied
Interventions
- OTHER COMPASS Intervention
Study Locations (20)
North Carolina
- CHS Stanly - Albemarle
- Mission Hospital - Asheville
- UNC Hospital - Chapel Hill
- CHS Carolinas Medical Center - Charlotte
- Novant Health Presbyterian Medical Center - Charlotte
- CHS Carolinas Medical Center-Mercy - Charlotte
- CHS University - Charlotte
- CHS Northeast - Concord
- Betsy Johnson Hospital - Dunn
- Morehead Memorial Hospital - Eden
- Hugh Chatham Memorial Hospital - Elkin
- Cape Fear Valley Medical Center - Fayetteville
- Angel Medical Center - Franklin
- Pardee Health - Hendersonville
- Frye Regional Medical Center - Hickory
- Novant Health Huntersville - Huntersville
- Onslow Memorial Hospital - Jacksonville
- Ashe Memorial Hospital - Jefferson
- Vidant Duplin Hospital - Kenansville
- CHS Kings Mountain - Kings Mountain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,024 participants |
| Start Date | 2016-07-25 |
| Est. Completion | 2020-03-15 |
| Phase | NA |
What the finished NCT02588664 record still lists
NCT02588664 is an interventional study that assigns participants to a tested intervention. Its 6,024 participants enrollment target places it among the larger protocols in the corpus, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which COMPASS Intervention is the first listed.
NCT02588664 names 20 study sites across 1 states, led by North Carolina.
Frequently Asked Questions
What is clinical trial NCT02588664 about?
NCT02588664 is a clinical study titled "Comprehensive Post-Acute Stroke Services". The purpose of this pragmatic study is to investigate whether implementation of a comprehensive post-acute stroke service model that integrates Early Supported Discharge (ESD) and Transitional Care Management (TCM) for stroke survivors discharged home improves functional outcomes post-stroke, reduce...
What is the current status of trial NCT02588664?
This trial is currently completed. It is a NA study. The enrollment target is 6,024 participants. The study started on 2016-07-25. Estimated completion is 2020-03-15.
What conditions does trial NCT02588664 study?
This clinical trial studies the following conditions: Stroke, Transient Ischemic Attack.
What interventions are being tested in trial NCT02588664?
The interventions under investigation include: COMPASS Intervention (OTHER).
Who is sponsoring clinical trial NCT02588664?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02588664 being conducted?
This trial has 20 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02588664's enrollment target sits among peer trials
6,024 10th of 454 higher than 445 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI